OTCMKTS:ABMC American Bio Medica (ABMC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC Filings About American Bio Medica Stock (OTCMKTS:ABMC) Get American Bio Medica alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview American Bio Medica Corporation was a life sciences company that developed, manufactured and marketed diagnostic testing products. Its primary business focused on rapid tests designed to detect drugs of abuse in biological samples, including urine and oral fluid. The company’s product offerings included point-of-care screening tests used by employers, law enforcement agencies, treatment providers and other organizations that required preliminary drug testing. American Bio Medica marketed its products under brands including Rapid Drug Screen and OralStat, subject to product availability and regulatory requirements. American Bio Medica was based in the United States and served institutional and professional customers through sales and distribution channels. Publicly available information about its current operations, leadership and geographic reach is limited, so additional details could not be confirmed.AI Generated. May Contain Errors. Read More Receive ABMC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ABMC Stock News HeadlinesAmerican Bio Medica Corp. (ABMC)April 17, 2026 | nasdaq.comAmerican Bio Medica CorpApril 19, 2024 | morningstar.comMA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down year in nearly two decades and total gains of almost 2,000% - his immediate reaction was disbelief. It took a trusted friend's personal vouching for Emmet Savage and a face-to-face trip to Ireland to change his mind. The full documentary, Investigating Project Prophet, is now live.September 26 at 1:00 AM | Porter & Company (Ad)Oxford Biomedica Solutions to Present Company Capabilities and its Platform at American Society of Gene and Cell Therapy in Los AngelesMay 9, 2023 | technews.tmcnet.comSpecimen Validity Testing Market 2023 with Regional Segmentations Forecast till 2030May 4, 2023 | marketwatch.comSpecimen Validity Testing Market Research, 2023-2030April 27, 2023 | marketwatch.comABMC American Bio Medica CorporationApril 27, 2023 | seekingalpha.comAmerican Bio Medica sells headquarters as part of asset sale to Healgen ScientificMarch 14, 2023 | bizjournals.comSee More Headlines ABMC Stock Analysis - Frequently Asked Questions How were American Bio Medica's earnings last quarter? American Bio Medica Corp. (OTCMKTS:ABMC) posted its quarterly earnings data on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The business earned $1.04 million during the quarter. How do I buy shares of American Bio Medica? Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of American Bio Medica own? Based on aggregate information from My MarketBeat watchlists, some other companies that American Bio Medica investors own include FuelCell Energy (FCEL), OPKO Health (OPK), Canadian Western Bank (CWB), Canopy Growth (CGC), Newmont (NEM), Cortex Pharmaceuticals (RSPI) and V Group (VGID). Company Calendar Last Earnings5/14/2018Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:ABMC CIK896747 Webwww.abmc.com Phone(518) 758-8158Fax518-758-8171Employees30Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (OTCMKTS:ABMC) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredIran War WARNING: Something Just ChangedA powerful Middle Eastern government is reportedly asking Trump for U.S. military help against Iran backed for...Banyan Hill Publishing | SponsoredAnalyst nicknamed “The Prophet” issues new warning for AmericaWhitney Tilson exposed a major company on 60 Minutes in an Emmy-winning investigation - the stock lost nearly ...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | Sponsored6 Elon Musk companies. The 1 FREE investor roadmap to them all.Elon Musk owns six companies, but most investors can only access four. Tesla, SpaceX, xAI, and X are public an...Zacks | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding American Bio Medica Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share American Bio Medica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.